Citi Pharma Limited (PSX:CPHL)
Pakistan
· Delayed Price · Currency is PKR 82.73
0.00 (0.00%)
At close: Jun 18, 2025
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 18.90 billion as of June 27, 2025. Its market cap has increased by 179.40% in one year.
Market Cap
18.90B
Enterprise Value
20.52B
Revenue
12.97B
Ranking
n/a
PE Ratio
22.74
Stock Price
82.73
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 18.90B, an increase of 164.54%. That is a compound annual growth rate of 27.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 18.90B | 21.47% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 124.33B |
| Abbott Laboratories (Pakistan) | 93.47B |
| AGP Limited | 53.24B |
| Highnoon Laboratories | 52.00B |
| The Searle Company | 44.49B |
| Shifa International Hospitals | 29.65B |
| Ferozsons Laboratories | 16.64B |
| Otsuka Pakistan | 3.54B |